College News - July 2008RCPE Press Release: Health Benefits From Scotland’s Smoking BanRoyal College of Physicians of Edinburgh (RCPE) The Royal College of Physicians of Edinburgh welcomes the public recognition this week by the prestigious New England Journal of Medicine of the evidence from Scotland of the major health benefits of a change in smoking policy. Professor Neil Douglas, President of the College and a respiratory physician in Edinburgh, said: “Smoking continues to be one of the most powerful influences on the health of Scots, and this research demonstrates the very rapid positive effect of discouraging this dangerous and addictive habit. It is now not acceptable to smoke in public places, and we are seeing the health benefits. It is important to maintain efforts to support people to stop smoking and to discourage our young people from taking up the habit. Plans to develop licensing schemes to enforce the law on age of purchase and efforts to remove tobacco products from open display in shops and supermarkets will all contribute to this end and should be supported." ENDS Contact: Graeme McAlister on 0131-247-3693 or 07808-939395 Added 31 July 2008 Chair - National Clinical Data for Quality Improvement Advisory GroupThe President would like to draw this important opportunity to the attention of all Fellows and Members in Scotland. This committee will be a sub committee of NHS QIS and will provide the chair with a real opportunity to influence the national strategy on audit, clinical outcomes and national clinical data collection. This is a key appointment and we hope physicians with an interest in audit and clinical effectiveness will consider it carefully. Added 28 July 2008 RCPE comment on plans for revalidation of doctors in UKThe RCPE has issued the following comment on the principles of revalidation announced by the DoH earlier today Prof Neil Douglas, President of the Royal College of Physicians of Edinburgh (RCPE), said, “We welcome the principles of the plans set out today for the process of revalidation. These plans will enable doctors to prove that they keep their skills up-to-date and will importantly reassure patients that all doctors will be in a position to provide the best possible level of care. “We look forward to working with the GMC in developing the clinical standards which doctors will be required to attain in order to be revalidated and the mechanisms to support doctors through this process.” ENDS Contact: Graeme McAlister on 0131-247-3693 or 07808-939395 Hyperlinks are supplied below to - Added 23 July 2008 2008 edition of the "Gold Guide" for specialty training now availableThe 2008 edition of A Reference Guide for Postgraduate Specialty Training in the UK (the "Gold Guide") and its Core Training Supplement are now available. These set out the arrangements applicable to trainees taking up appointments which commence on or after 6 August 2008. A new edition was required to cover the introduction of core training programmes in specialties that "uncoupled" with effect from 6 August 2008. Please note that trainees taking up appointments in specialty training between 1 August 2007 and 5 August 2008 will continue to be covered by the 2007 edition. Added 04 July 2008 Vacancy - Editor in Chief of The European Journal of Internal MedicineExpressions of interest are invited for the above post from Fellows and Collegiate Members who are resident in the UK or Europe. Support, both financially and in staffing, will be provided by Elsevier (who publish the Journal) in consultation with the European Federation of Internal Medicine (EFIM). Expressions of interest should be emailed to: c.gray@rcpe.ac.uk by Friday 25 July. However, the final choice will be made by EFIM’s Executive Committee in close collaboration with the Editors and Elsevier. After that an agreement between the new Editor in Chief, EFIM and Elsevier will be drawn up. Requirements are:
In addition, Elsevier have mentioned the following important points: “The role as the Editor-in-Chief of the European Journal of Internal Medicine includes ensuring high scientific standards of papers and sufficient copyflow, with responsibility for the timely coordination of editing, refereeing, submissions, and communications with authors, as well as ensuring that such activities are done in conformity with the Editorial Policies and good publishing practices. Good publishing practices also involve using all reasonable efforts to ensure that published papers and their authors abide by scientific standards for integrity and objectivity, do not infringe the proprietary rights of others, do not defame others, and do not cause damage or harm to persons or property or to the good reputation of the Journal. Such practices also include efficient and timely administration of the process of receiving papers and submitting the papers for the review, publication and production. The Editorial Board for the Journal is selected on the basis of expertise and standing within the scientific discipline, reflection of the actual or anticipated geographic scope of the Journal, the expected positive impact on the number and quality of papers submitted, and for assistance in the refereeing process. As Editor-in-Chief, you may nominate candidates for appointment to the Editorial Board (and will make recommendations regarding removals), which candidates may (at the discretion of Elsevier) be officially appointed or removed by Elsevier. Other editors may be appointed from time to time for subsidiary roles for the Journal, which editors will be nominated and appointed in the same fashion noted above for members of the Editorial Board. As the Editor-in-Chief you agree that, during the term of your editorship, you will not perform editorial activities for any other scientific journal which may reasonably be considered as being in competition with the Journal and you shall observe the interests of the Journal and abstain from any action that will be detrimental to the Journal. This does not prohibit acting as a reviewer or participation in editorial boards for other journals. The Society’s appointment of you as Editor-in-Chief is predicated on the idea that your personal services are of the essence and that the Society shall not be obligated to accept any substitute performance.” The institutional members of EFIM are: Bristol-Myers Squibb Europe (France), Amgen Europe (Switzerland), Gilead Sciences (France), Pfizer (Netherlands), Servier International (France) DEADLINE FOR EMAILED EXPRESSIONS OF INTEREST Added 02 July 2008
|
 |
 |